Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001680367-22-000034
Filing Date
2022-11-09
Accepted
2022-11-09 06:07:31
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sttk-20220930.htm   iXBRL 10-Q 934621
2 EX-31.1 sub-certxsection302xceoxq3.htm EX-31.1 17375
3 EX-31.2 sub-certxsection302xcfoxq3.htm EX-31.2 17315
4 EX-32.1 sub-certxsection906ofthesa.htm EX-32.1 9273
  Complete submission text file 0001680367-22-000034.txt   4471523

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20220930.xsd EX-101.SCH 27912
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20220930_cal.xml EX-101.CAL 47884
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20220930_def.xml EX-101.DEF 107648
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20220930_lab.xml EX-101.LAB 415551
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20220930_pre.xml EX-101.PRE 257220
47 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20220930_htm.xml XML 668434
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39593 | Film No.: 221370534
SIC: 2834 Pharmaceutical Preparations